Crowdonomics
Biostate AI, Inc

Reg CF · SAFE · Apr 2026

ClosedReached targetReg CFSAFE
via WeFunder · last checked Aug 25, 2026
Raised
$659K / $618K max
100% of ceiling
Investors
481
$1.4K avg
Valuation
—
—

Financials disclosed in this offering

FY2024–FY2025 · hover for source
$67K
−$5.4M
FY2024
$565K
−$9.9M
FY2025
RevenueNet income
Metric
FY2024 reviewed
FY2025 reviewed
Income statement
Revenue
$66,700
$565,452
Cost of goods sold
$104,466
$690,981
Gross margin
-57%
-22%
Net income
-$5,407,609
-$9,881,728
Taxes paid
$0
$0
Balance sheet
Cash
$1,694,986
$2,348,306
Accounts receivable
$7,040
$147,764
Total assets
$3,420,773
$4,485,898
Short-term debt
$913,728
$2,501,635
Long-term debt
$8,616,179
$1,065,588
Total liabilities
$9,529,907
$3,567,223
Other
Headcount
—
20

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Jul 14, 2026
    • Maximum $53.4K → $618K

    “Adding CPA reviewed financials and upping maximum”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$50,000
Max$618,000
Min investment—
OpenedApr 17, 2026
DeadlineApr 30, 2027
ClosedAug 25, 2026
Days active130

Links & provenance

Source: SEC EDGAR
0001990762-26-000005
Last synced Aug 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.